ecrin-mdr-crcClinical2006Adenocarcinoma colorrectal metastásico.Metastatic Colorectal CancerColorectal NeoplasmsMetastatic Colorectal CancerColorectal NeoplasmsAdenocarcinoma Colorrectal Metastásico.Interventionalhttps://newmdr.ecrin.org/Study/2030383Spain6OxaliplatinoCapecitabinaOxaliplatinFirst lineCapecitabineBevacizumabECRIN MDRCompletedfalse1stline Study Capecitabine Administered on Continuous Way Plus Oxaliplatin&Bevacizumab Every 2weeks in Metastatic CCR.The purpose of this study is to determinate progression free survival after 9 months of treatment.2006-06-152030383NCT003456962005-006171-12